VVT Medical, a developer of minimally invasive treatments for venous insufficiency, announced that it has received conditional approval from the TSXv to list its common shares. The Kfar Saba, Israel–based company has already secured $6.5 million … [Read More...] about VVT Medical plans to go public on Toronto exchange
Main Content
Medical Tubing & Extrusion
VVT Medical plans to go public on Toronto exchange
VVT Medical, a developer of minimally invasive treatments for venous insufficiency, announced that it has received conditional approval from the TSXv to list its common shares. The Kfar Saba, Israel–based company has already secured $6.5 million … [Read More...] about VVT Medical plans to go public on Toronto exchange
Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study
Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million. The clinical-stage Shifamed portfolio company also recently completed enrollment for its U.S. SUPPORT I Early Feasibility Study … [Read More...] about Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study
Evident Vascular closes Series B for AI-powered intravascular ultrasound
Evident Vascular announced today that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS) platform. The San Jose, California–based company did not disclose the amount raised in the Series B round. It adds … [Read More...] about Evident Vascular closes Series B for AI-powered intravascular ultrasound
FDA clears Imperative Care’s Symphony 16F 82cm catheter
Imperative Care today announced FDA 510(k) clearance of its Symphony 16 Fr 82cm catheter for venous thrombosis and announced the first successful cases. Campbell, California-based Imperative Care said the catheter joins the Symphony Thrombectomy … [Read More...] about FDA clears Imperative Care’s Symphony 16F 82cm catheter
Abbott is making an IVL play with FDA IDE nod
Abbott announced today that it received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system. IDE enables the company to evaluate the system in treating severe calcification in coronary … [Read More...] about Abbott is making an IVL play with FDA IDE nod
How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach
Shockwave’s novel Javelin intravascular lithotripsy catheter focuses acoustic energy forward to clear a path through calcium-clogged blood vessels. Johnson & Johnson MedTech’s Shockwave Medical aims to deliver intravascular lithotripsy (IVL) to … [Read More...] about How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach
Medtronic recalls embolization device after reported deaths
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the device. The recall involves removing Pipeline Vantage 027 device models from use and sale and updating instructions for … [Read More...] about Medtronic recalls embolization device after reported deaths
